Ipratropium clinical trials
Also written Atrovent.
Counted the way a researcher would: Ipratropium with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Ipratropium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Ipratropium studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Dec 1986 · ATROVENT · NDA 019085 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
39 studies that test it; most in 2002 (5)
| Year | Studies |
|---|---|
| 1998 | 4 |
| 1999 | 1 |
| 2002 | 5 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 2 |
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 23
Boehringer Ingelheim (9) · GlaxoSmithKline (3) · Neutec Ar-Ge San ve Tic A.Ş (2) · Oregon Health and Science University (1) · State University of New York at Buffalo (1) · Haukeland University Hospital (1) · MetroHealth Medical Center (1) · University of California, San Francisco (1)
Often tested with
Tested in the same studies.
Albuterol (14) · Tiotropium (3) · Levalbuterol (2) · Fenoterol (2) · Propranolol (1) · Ensifentrine (1) · Arformoterol tartrate (1) · Budesonide (1)
Related medicines
As reviewed, each with the page that says it.
- One of Bronchodilators source
- One of Cholinergic Antagonists source
- One of Antimuscarinics source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Ipratropium is the comparator. A study of two new drugs counts under both.
- 1Glycopyrrolate · Post Graduate Institute of Medical Education and Research, Chandigarh
Studies
Open first, then newest update. How each study uses Ipratropium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 40
- Effect of Ipratropium Bromide on EILONot yet recruitingPhase 2Cook Children's Health Care SystemNCT07394036Written as Ipratropium BromideHow we know
- Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)RecruitingNot applicableHat Yai Medical Education CenterNCT05550402Written as Ipratropium BromideHow we know
- Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsRecruitingPhase 3Neutec Ar-Ge San ve Tic A.ŞNCT05890638Written as Ipratropium / Levosalbutamol Fixed Dose CombinationHow we know
- Treating Respiratory Emergencies in Children StudyCompletedPhase 2Oregon Health and Science UniversityNCT06074185Written as Ipratropium BromideHow we know
- Defining and Treating Depression-related AsthmaCompletedEarly Phase 1State University of New York at BuffaloNCT04617015Written as Ipratropium BromideHow we know
- Atrovent in Exercise Induced Laryngeal Obstruction (EILO)CompletedPhase 1/2Haukeland University HospitalNCT02755714Written as Ipratropium bromide sprayHow we know
- Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsActive, not recruitingPhase 3Neutec Ar-Ge San ve Tic A.ŞNCT06040424Written as Ipratropium / Levosalbutamol Fixed Dose CombinationHow we know
- A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma ExacerbationCompletedNot applicableMetroHealth Medical CenterNCT00583778Written as ipratropiumHow we know
- Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)TerminatedPhase 4Wake Forest University Health SciencesNCT03219866Written as AtroventHow we know
- Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in AthletesCompletedPhase 4University of California, San FranciscoNCT01691079Written as ipratropium bromideHow we know
- Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial HypertensionWithdrawnPhase 3Assistance Publique - Hôpitaux de ParisNCT02782052Written as Nebulized ipratropium bromideHow we know
- Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized BronchodilatorStatus unknownNot applicableUniversidade Federal do Rio Grande do NorteNCT03271905Written as salbutamol sulfate and ipratropium bromideHow we know
- Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status AsthmaticusCompletedPhase 1University Hospitals Cleveland Medical CenterNCT02872597Written as IpratropiumHow we know
- Ipratropium Bromide Spray as Treatment for Sialorrhea in ChildrenStatus unknownPhase 2London Health Sciences CentreNCT03747536Written as Ipratropium bromideHow we know
- A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and IpratropiumCompletedPhase 4GlaxoSmithKlineNCT01691482Written as IpratropiumHow we know
- Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPDCompletedPhase 1Pneuma Respiratory, IncNCT03480997Written as Albuterol Sulfate and Ipratropium BromideHow we know
- Ipratropium Spray for Drooling Saliva in Parkinson's DiseaseCompletedPhase 2University Health Network, TorontoNCT00296946Written as ipratropium bromide (drug)How we know
- Optimising the Propranolol Block ModelCompletedPhase 1GlaxoSmithKlineNCT00549120Written as IpratropiumHow we know
- Helium-3 MRI Imaging Study in COPDCompletedPhase 1GlaxoSmithKlineNCT02207452Written as IpratropiumHow we know
- Ipratropium Bromide in Peri-Operative COPDCompletedPhase 4Boehringer IngelheimNCT01943552Written as ipratropium bromideHow we know
See all 40 studies that test Ipratropium →
Given beside what is tested · 6 — Ipratropium is usual care or a partner of the new treatment
- Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly GenotypesCompletedNot applicableColumbia UniversityNCT00521222Written as Ipratropium HFAHow we know
- Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Mylan Inc.NCT03064113Written as Ipratropium 500 μgHow we know
- Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedPhase 4AstraZenecaNCT01415518Written as Drug: ipratropium (AtroventTM)How we know
- Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.CompletedPhase 3Northwell HealthNCT00588406Written as Ipratropium bromideHow we know
- Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma ExacerbationStatus unknownPhase 4Hospital General Naval de Alta Especialidad - Escuela Medico NavalNCT02584738Written as Ipratropium bromideHow we know
- Budesonide Inhalation Suspension for Acute Asthma in ChildrenCompletedPhase 4Children's Hospital of PhiladelphiaNCT00393367Written as Albuterol, ipratropium bromideHow we know
As the comparator · 11 — what is tested is compared with Ipratropium
- Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)Not yet recruitingPhase 4University of Tennessee Graduate School of MedicineNCT07721922Written as Ipratropium BromideHow we know
- A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible BronchoscopyNot yet recruitingPhase 2/3Post Graduate Institute of Medical Education and Research, ChandigarhNCT06376942Written as IpratropiumHow we know
- Revefenacin in Acute Respiratory Insufficiency in COPDCompletedPhase 2University of California, Los AngelesNCT04315558Written as Ipratropium BromideHow we know
- Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary DiseaseCompletedPhase 3Boehringer IngelheimNCT02172443Written as AtroventHow we know
- PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Pearl Therapeutics, Inc.NCT01350128Written as Ipratropium Bromide HFA Inhalation AerosolHow we know
- Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 StudyCompletedPhase 2Sunovion Respiratory Development Inc.NCT01426009Written as Ipratropium bromide Inhalation Solution via Handihaler® DPIHow we know
- Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of AsthmaStatus unknownNot applicableUniversity of British ColumbiaNCT03296579Written as IpratropiumHow we know
- Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary DiseaseCompletedPhase 3Boehringer IngelheimNCT01019694Written as Atrovent HFA 42 mcg + Albuterol HFA 200 mcgHow we know
- Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary DiseaseCompletedPhase 3Boehringer IngelheimNCT02177344Written as AtroventHow we know
- Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3Boehringer IngelheimNCT02172469Written as Ipratropium Bromide Metered Dose InhalerHow we know
- Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedPhase 3University of MonastirNCT01136421Written as Ipratropium bromideHow we know
Codes
What other systems call Ipratropium · ClinicalTrials.gg INT007861
- MeSH (NLM) D009241IpratropiumConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) GR88G0I6ULIPRATROPIUMConfirmed FDA, NLM
- RxNorm 1546373One source FDA
- NCI Thesaurus C61794IpratropiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009241 | Ipratropium | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | GR88G0I6UL | IPRATROPIUM | Confirmed FDA, NLM |
| RxNorm | 1546373 | — | One source FDA |
| NCI Thesaurus | C61794 | Ipratropium | One source FDA |
Also registered as ipratropium bromide (UNII J697UZ2A9J · RxNorm 1309404) and ipratropium bromide anhydrous (UNII VJV4X1P2Z1).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.